EUVIMEDEUVIMED entdecken
Kommentar

Programmable cellular protein factories

Richard G James, Ting-Ting Zhang

Science · 16.04.2026 · 392 (6795) · 252-253

DOI: 10.1126/science.aeg7084 ↗

Kurz gefasst

Kommentar in der Zeitschrift Science, erschienen am 16.04.2026. Verfasst von Richard G James und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunity and Immunotherapies , Seattle Children's Research Institute, Seattle, WA, USA. Hauptthemen laut MEDLINE: Antibodies, Cell Engineering, Precursor Cells, B-Lymphoid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Engineered immune cell precursors produce antibodies on demand in mice

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntibodiesCell EngineeringPrecursor Cells, B-LymphoidAnimalsMice

Substanzen

Antibodies

Autor:innen und Institutionen

  • Center for Immunity and Immunotherapies , Seattle Children's Research Institute, Seattle, WA, USA.
  • Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.

Zitieren

APA

James, R. G., & Zhang, T. T. (2026). Programmable cellular protein factories. Science, 392(6795), 252-253. https://doi.org/10.1126/science.aeg7084

Vancouver

James RG, Zhang TT. Programmable cellular protein factories. Science. 2026;392(6795):252-253. doi:10.1126/science.aeg7084

BibTeX
@article{James2026,
  author = {James, Richard G and Zhang, Ting-Ting},
  title = {Programmable cellular protein factories},
  journal = {Science},
  year = {2026},
  volume = {392},
  number = {6795},
  pages = {252--253},
  doi = {10.1126/science.aeg7084}
}
Kostenlos starten →